Navigation Links
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Date:11/24/2008

on (CRO).

NOTE: Office Blood Pressure Measurements (OBPMs) were performed by a health care professional during a patient's visit to the treatment center using a standard technique and equipment (i.e. a sphygmomanometer). OBPMs were performed in the morning and the time between intake of study-drug and measurement of OBPM was between 2 and 4 hours.

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is a product-driven biopharmaceutical company dedicated to the development and future commercialization of investigational drugs for unmet medical needs. NicOx is applying its proprietary nitric oxide-donating technology to develop an internal portfolio of New Chemical Entities (NCEs) in the therapeutic areas of inflammatory and cardio-metabolic disease.

Resources are focused on the development and pre-commercialization activities for naproxcinod, a proprietary NCE and the first compound in the Cyclooxygenase-Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents for the treatment of the signs and symptoms of osteoarthritis. Naproxcinod has completed three pivotal phase 3 studies with positive results and the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) is projected for mid-2009.

Beyond naproxcinod, NicOx has a pipeline containing multiple nitric oxide-donating NCEs, which are in development internally and with partners, including Pfizer Inc and Merck & Co., Inc., for the treatment of prevalent and underserved diseases, such as atherosclerosis, hypertension, widespread eye diseases and Chronic Obstructive Pulmonary Disease (COPD).

NicOx S.A. is headquartered in France and is listed on the NYSE Euronext Paris (Compartment B: Mid Caps).

This press release contains certain forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statemen
'/>"/>

SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

13611

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
4. CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
5. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
6. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
7. NewCardio Announces Positive Results From Third Clinical Validation Study
8. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
9. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
10. NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
11. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... PositiveID Corp. (OTCQB: PSID), based in ... emerging player in the bio-threat detection market, that ... rapid medical testing. The Company,s proprietary airborne pathogen ... Detector), was developed under contract with the U.S. ... directorate, and $30 million of contract funding. ...
(Date:7/23/2014)...  Researchers from the North American Menopause Society (NAMS) ... levels too high, 1 putting women at risk ... Women close to menopause are commonly told to take ... such as osteoporosis, to which they are particularly prone. ... much calcium they typically get through their food sources ...
(Date:7/23/2014)... 2014 This September leading clinicians in orthodontics ... Vegas for DOCtalk 2014 —a "Dynamic ... thinker and private practitioner Dr. David Sarver , ... discuss clinical and practice management efficiency and high quality ... opportunity to welcome fresh thinking and join a community ...
Breaking Medicine Technology:PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Women Taking Too Much Calcium Create Health Risk 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... According to Millennium Research Group (MRG), the global authority ... in the US ultrasound system market last year. Not only ... in the market, but it also earned a strong presence ... diverse portfolio has enabled GE to maintain a solid lead ...
... Sept. 27 CareFusion (NYSE: ... company, has announced it has entered into ... and sell innovative surgical scrub solutions, including ... Surgical Scrub and Triseptin® Hand and Body ...
Cached Medicine Technology:GE Healthcare Set to Take Share from Siemens and Philips in the $1.2 Billion US Ultrasound Market 2GE Healthcare Set to Take Share from Siemens and Philips in the $1.2 Billion US Ultrasound Market 3CareFusion Expands Skin Antisepsis Portfolio 2CareFusion Expands Skin Antisepsis Portfolio 3CareFusion Expands Skin Antisepsis Portfolio 4CareFusion Expands Skin Antisepsis Portfolio 5
(Date:7/23/2014)... Steven Reinberg HealthDay Reporter ... obese and overweight American children and teens look in ... U.S. health officials reported Wednesday. "Being overweight or ... high blood pressure, high cholesterol and diabetes," said lead ... Centers for Disease Control and Prevention,s National Center for ...
(Date:7/23/2014)... The next episode of “Extreme Weight Loss” ... was physically fit through childhood and adolescence. After becoming ... heart-wrenching decision to give her son up for adoption. ... years, and she punished herself by overeating, gaining nearly ... non-competitive approach to weight loss transformations, “Extreme Weight Loss” ...
(Date:7/23/2014)... Home Care Assistance Calgary , ... is proud to announce the next installment in its ... wide range of health and wellness-related fields. The upcoming ... author Nancy Kriseman, and will cover the most common ... by becoming more self-aware. In particular, Nancy will discuss ...
(Date:7/23/2014)... July 23, 2014 (HealthDay News) -- Painful or itchy ... cancer, researchers report. "Patients sometimes have multiple lesions ... or painful should raise high concerns for non-melanoma skin ... at Temple University School of Medicine, said in a ... at the medical records of 268 patients who were ...
(Date:7/23/2014)... study supports a growing body of research suggesting ... hormones in treating postmenopausal breast cancer, with fewer ... with standard anti-hormone therapies. The study will be ... journal Reproductive Biology and Endocrinology . , ... in women in the United States. Approximately 70% ...
Breaking Medicine News(10 mins):Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3Health News:“Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Painful, Itchy Patches Could Be Sign of Skin Cancer 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5
... China,s Largest Distributor of Medical and Dental ... Anesthetic Delivery System to China,s Dental IndustryLIVINGSTON, ... (OTC Bulletin Board: MLSS), the recognized leader ... it has granted China National Medicines Corporation, ...
... CHAPEL HILL, N.C., April 29 TSI Healthcare, a ... Management and Electronic Health Records (EHR) Systems, announces the ... in Chapel Hill, NC. TSI,s new space includes ... located directly behind the Sheraton Chapel Hill Hotel in ...
... to Clean Up Its ActNEW YORK, April 29 ... children,s health by introducing the Safe Baby Products Act, ... regulate hazardous contaminants in personal care products marketed to ... to a study by the Campaign for Safe Cosmetics, ...
... can help lessen the riskATLANTA, April 29 The ... created a standard that offers guidance on air quality ... lessen the risk of all disease exposure -- including ... airborne transmission is only one way in which disease ...
... 15th SPSSCS Annual Meeting , ... New York, NY (Vocus) April 29, ... its 15th Annual Meeting - Play the Winning Hand: Watching Your Fortunes ... The meeting offers educational seminars for nurses, aestheticians and other ...
... /PRNewswire/ -- Aesthetic Medical Educators Training ... professionals on Aesthetic Procedures over the past five ... include physicians, nurses, physician assistants and dentists, all ... his/her practice.These medical professionals have been trained on ...
Cached Medicine News:Health News:Milestone Scientific Grants Sinopharm Exclusive Distribution and Marketing Rights to STA System in China 2Health News:Milestone Scientific Grants Sinopharm Exclusive Distribution and Marketing Rights to STA System in China 3Health News:Milestone Scientific Grants Sinopharm Exclusive Distribution and Marketing Rights to STA System in China 4Health News:TSI Healthcare Announces Relocation of Corporate Headquarters to Chapel Hill, NC 2Health News:New Federal Legislation Targets Toxic Chemicals in Baby Bath Products 2Health News:Aviation Ventilation Expert Available to Speak About Swine Flu Spread on Airplanes 2Health News:Play the Winning Hand - Watching Your Fortunes Grow in Skin Care 2Health News:Play the Winning Hand - Watching Your Fortunes Grow in Skin Care 3Health News:Aesthetic Medical Educators Training Successfully Trains Over 2,000 Medical Professionals on Aesthetic Procedures 2
... Flexoscope images are transmitted through ... the picture and transmit it ... Storz flexoscopes are designed for ... be repaired at low cost ...
... BAK/Proximity Interbody Fusion system ... and associated implantation instruments. ... a hollow, porous, square-threaded ... alloy (Ti-6Al-4V). Hollow, porous ...
The flexible endoscope was mainly developed for the pure neuroendoscopy. Due to the working channel it is ideal suitable for therapeutic indications e.g. subdural hematomas, cysts or intraventricular...
... Low Profile Ergonomic Design for ... neuroendoscopes are designed for therapeutic minimally ... of configurations, these scopes offer working ... capabilities. With a flexible body and ...
Medicine Products: